Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis
NCT02874586 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-11-10
Summary
An open-label,pilot study to evaluate the efficacy and safety of plasma exchange combination of immunosuppressive regimens, for the remission of autoimmune hepatitis (AIH).
Conditions
- Hepatitis, Autoimmune
Interventions
- OTHER
-
Plasma exchange combination of immunosuppressive regimens
Sponsors & Collaborators
-
Xiaoli Fan
lead OTHER
Principal Investigators
-
Li Yang, MD · West China Hospital,Chengdu, Sichuan, China
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2021-04-30
- Completion
- 2021-09-30
Countries
- China
Study Locations
More Related Trials
-
Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis
NCT02910258 ·Status: COMPLETED
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
NCT00104299 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients
NCT06099236 ·Status: ACTIVE_NOT_RECRUITING
-
Sirolimus in the Treatment of Refractory/Relapsed wAIHA
NCT05925023 ·Status: RECRUITING ·Phase: NA
-
Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
NCT01731561 ·Status: COMPLETED ·Phase: PHASE3
-
MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
NCT00301652 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)
NCT06656962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)
NCT05962840 ·Status: RECRUITING ·Phase: PHASE4
-
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
NCT02647255 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy
NCT00302510 ·Status: COMPLETED ·Phase: NA
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.
NCT07000292 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800 ·Status: RECRUITING ·Phase: PHASE3
-
Withdraw Drug in Stable IgG4-Related Disease
NCT04124861 ·Status: UNKNOWN ·Phase: NA
-
Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
NCT01539902 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
NCT04889430 ·Status: COMPLETED ·Phase: PHASE3
-
Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis
NCT03316651 ·Status: UNKNOWN ·Phase: PHASE2
-
A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
NCT02160132 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA
NCT04944524 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis
NCT03096275 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Two Treatments in the Remission of Vasculitis
NCT00748644 ·Status: COMPLETED ·Phase: PHASE3